BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc. (OTCBB: URGP, http://www.urigen.com), a specialty pharmaceutical company focused on the development and commercialization of treatments for urological disorders, today announced that it will conduct a live webcast to provide a complete review of the Company’s development programs at 11:00 a.m. EST on Thursday, March 13, 2008.
